Variant report

Variant	nsv933980
Chromosome Location	chr13:48431000-48557419
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:459)
CpG islands
(count:184)
Chromatin interactive
region (count:15)
LncRNA
region (count:16)
Mature miRNA
region (count: 0)
miRNA target
sites (count:1)

(count:459 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr13:48432383-48432990	HepG2	liver:	n/a	n/a
2	ARID3A	chr13:48507091-48507891	HepG2	liver:	n/a	n/a
3	ATF1	chr13:48535753-48535873	K562	blood:	n/a	n/a
4	ATF1	chr13:48519960-48520268	K562	blood:	n/a	n/a
5	BHLHE40	chr13:48443796-48444273	GM12878	blood:	n/a	n/a
6	BHLHE40	chr13:48432486-48432688	HepG2	liver:	n/a	n/a
7	CBX3	chr13:48511322-48511529	K562	blood:	n/a	n/a
8	CBX3	chr13:48478334-48478745	K562	blood:	n/a	n/a
9	CEBPB	chr13:48432390-48432769	HepG2	liver:	n/a	n/a
10	CEBPB	chr13:48439601-48439930	HepG2	liver:	n/a	chr13:48439760-48439771 chr13:48439758-48439769 chr13:48439760-48439771
11	CEBPB	chr13:48519785-48520560	IMR90	lung:	n/a	n/a
12	CEBPB	chr13:48519823-48520314	Hela-S3	cervix:	n/a	n/a
13	CEBPB	chr13:48545382-48545424	HepG2	liver:	n/a	n/a
14	CEBPB	chr13:48545301-48545796	A549	lung:	n/a	chr13:48545362-48545373
15	CEBPB	chr13:48545381-48545581	IMR90	lung:	n/a	n/a
16	CEBPB	chr13:48470738-48471049	HepG2	liver:	n/a	n/a
17	CEBPB	chr13:48477973-48478318	Hela-S3	cervix:	n/a	n/a
18	CEBPB	chr13:48477968-48478327	IMR90	lung:	n/a	n/a
19	CEBPB	chr13:48545357-48545703	MCF-7	breast:	n/a	chr13:48545362-48545373
20	CEBPB	chr13:48519847-48520325	A549	lung:	n/a	n/a
21	CEBPB	chr13:48545387-48545562	K562	blood:	n/a	n/a
22	CEBPB	chr13:48507391-48507955	HepG2	liver:	n/a	n/a
23	CEBPB	chr13:48478013-48478293	K562	blood:	n/a	n/a
24	CEBPB	chr13:48545330-48545733	A549	lung:	n/a	chr13:48545362-48545373
25	CEBPB	chr13:48533882-48534260	HepG2	liver:	n/a	n/a
26	CEBPB	chr13:48545359-48545622	Hela-S3	cervix:	n/a	chr13:48545362-48545373
27	CEBPB	chr13:48464470-48464557	IMR90	lung:	n/a	n/a
28	CEBPB	chr13:48519919-48520308	K562	blood:	n/a	n/a
29	CEBPB	chr13:48533959-48534237	IMR90	lung:	n/a	n/a
30	CEBPB	chr13:48519886-48520328	HepG2	liver:	n/a	n/a
31	CEBPB	chr13:48545353-48545646	A549	lung:	n/a	chr13:48545362-48545373
32	CEBPB	chr13:48439669-48439786	HepG2	liver:	n/a	chr13:48439760-48439771 chr13:48439758-48439769 chr13:48439760-48439771
33	CEBPB	chr13:48464349-48464658	Hela-S3	cervix:	n/a	n/a
34	CEBPB	chr13:48533959-48534214	A549	lung:	n/a	n/a
35	CEBPZ	chr13:48533659-48533859	HepG2	liver:	n/a	n/a
36	CEBPZ	chr13:48432918-48432928	HepG2	liver:	n/a	n/a
37	CREB1	chr13:48478335-48478941	K562	blood:	n/a	n/a
38	CTCF	chr13:48539100-48539250	RPTEC	kidney:	n/a	n/a
39	CTCF	chr13:48450320-48450470	AoAF	blood vessel:	n/a	n/a
40	CTCF	chr13:48539120-48539270	AG04449	skin:	n/a	n/a
41	CTCF	chr13:48539140-48539290	HRPEpiC	eye:	n/a	n/a
42	CTCF	chr13:48508992-48509070	Fibrobl	skin:	n/a	n/a
43	CTCF	chr13:48433400-48433550	BJ	skin:	n/a	chr13:48433455-48433464 chr13:48433455-48433468
44	CTCF	chr13:48467440-48467590	HAc	cerebellar:	n/a	n/a
45	CTCF	chr13:48433280-48433430	BJ	skin:	n/a	n/a
46	CTCF	chr13:48539080-48539230	HMEC	breast:	n/a	n/a
47	CTCF	chr13:48539060-48539210	AG04450	lung:	n/a	n/a
48	CTCF	chr13:48513360-48513510	HCPEpiC	choroid plexus:	n/a	n/a
49	CTCF	chr13:48482320-48482470	HCPEpiC	choroid plexus:	n/a	n/a
50	CTCF	chr13:48539120-48539270	HEEpiC	esophagus:	n/a	n/a

(count:184 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr13:48507440-48507490	NH-A	brain:	n/a
2	chr13:48507440-48507490	NH-A	brain:	n/a
3	chr13:48478591-48478641	Hela-S3	cervix:	n/a
4	chr13:48478591-48478641	HPAEpiC	pulmonary alveolar:	n/a
5	chr13:48507440-48507490	HPAEpiC	pulmonary alveolar:	n/a
6	chr13:48478591-48478641	AoSMC	blood vessel:	n/a
7	chr13:48478546-48478596	PFSK-1	brain:	n/a
8	chr13:48507440-48507490	GM12878	blood:	n/a
9	chr13:48478546-48478596	ovcar-3	ovarian:	n/a
10	chr13:48478591-48478641	GM12891	blood:	n/a
11	chr13:48507440-48507490	AG04449	skin:	fetal
12	chr13:48478591-48478641	SAEC	small airway:	n/a
13	chr13:48478591-48478641	MCF10A-Er-Src	breast:	n/a
14	chr13:48507440-48507490	IMR90	lung:	fetal
15	chr13:48478591-48478641	HMEC	breast:	n/a
16	chr13:48478546-48478596	Hela-S3	cervix:	n/a
17	chr13:48507440-48507490	SAEC	small airway:	n/a
18	chr13:48478591-48478641	GM06990	blood:	n/a
19	chr13:48507440-48507490	K562	blood:	n/a
20	chr13:48478546-48478596	ECC-1	luminal epithelium:	n/a
21	chr13:48478546-48478596	PrEC	prostate:	n/a
22	chr13:48478546-48478596	HCPEpiC	choroid plexus:	n/a
23	chr13:48478591-48478641	HEEpiC	esophagus:	n/a
24	chr13:48507440-48507490	PrEC	prostate:	n/a
25	chr13:48478591-48478641	AG10803	skin:	n/a
26	chr13:48478591-48478641	HCT-116	colon:	n/a
27	chr13:48478591-48478641	GM12878	blood:	n/a
28	chr13:48507440-48507490	AoSMC	blood vessel:	n/a
29	chr13:48507440-48507490	NHBE	bronchial:	n/a
30	chr13:48507440-48507490	PFSK-1	brain:	n/a
31	chr13:48478546-48478596	HL-60	blood:	n/a
32	chr13:48507440-48507490	HEEpiC	esophagus:	n/a
33	chr13:48478546-48478596	HNPCEpiC	eye:	n/a
34	chr13:48478546-48478596	HCT-116	colon:	n/a
35	chr13:48478546-48478596	HMEC	breast:	n/a
36	chr13:48478591-48478641	A549	lung:	n/a
37	chr13:48478546-48478596	GM12878	blood:	n/a
38	chr13:48478591-48478641	HCM	heart:	n/a
39	chr13:48507440-48507490	HEK293	kidney:	embryo
40	chr13:48507440-48507490	HNPCEpiC	eye:	n/a
41	chr13:48478546-48478596	Hepatocyte	liver:	n/a
42	chr13:48478591-48478641	NB4	blood:	n/a
43	chr13:48478591-48478641	AG09309	skin:	n/a
44	chr13:48478591-48478641	BJ	skin:	n/a
45	chr13:48507440-48507490	HRCEpiC	kidney:	n/a
46	chr13:48507440-48507490	HepG2	liver:	n/a
47	chr13:48478591-48478641	ovcar-3	ovarian:	n/a
48	chr13:48478591-48478641	Caco-2	colon:	n/a
49	chr13:48478546-48478596	Caco-2	colon:	n/a
50	chr13:48478591-48478641	GM12892	blood:	n/a

(count:15 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr13:48480107..48482697-chr13:48488766..48491546,2	K562	blood:
2	chr13:48371410..48374198-chr13:48468261..48469829,2	MCF-7	breast:
3	chr13:48538759..48539557-chr13:48611829..48612654,2	MCF-7	breast:
4	chr13:48501618..48503669-chr13:48506224..48510200,3	K562	blood:
5	chr13:48466792..48469518-chr13:48521553..48523936,2	MCF-7	breast:
6	chr13:48508669..48510249-chr13:48511199..48513558,2	K562	blood:
7	chr13:48400233..48402500-chr13:48467712..48470091,2	MCF-7	breast:
8	chr13:48541315..48543966-chr13:48557894..48560541,2	K562	blood:
9	chr13:48440591..48443452-chr13:48454032..48455862,2	MCF-7	breast:
10	chr13:48526596..48528652-chr13:48529280..48532198,2	K562	blood:
11	chr13:48556085..48558397-chr13:48568494..48570319,2	K562	blood:
12	chr13:48526596..48528652-chr13:48529280..48532198,2	K562	blood:
13	chr13:48440591..48443452-chr13:48454032..48455862,2	MCF-7	breast:
14	chr13:48449894..48450717-chr7:134300210..134301125,2	MCF-7	breast:
15	chr13:48470064..48472473-chr13:48479999..48482410,2	MCF-7	breast:

(count:16 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SUCLA2-3	chr13:48481153-48481270	NONHSAT033689
2	lnc-SUCLA2-4	chr13:48466673-48466696	XLOC_010601
3	lnc-SUCLA2-3	chr13:48503273-48504009	NONHSAT033689
4	lnc-SUCLA2-3	chr13:48443896-48444401	NONHSAT033689
5	lnc-SUCLA2-1	chr13:48513402-48513514	XLOC_010602
6	lnc-SUCLA2-3	chr13:48479464-48479533	ENSG00000234689
7	lnc-SUCLA2-3	chr13:48481466-48481492	ENSG00000234689
8	lnc-SUCLA2-3	chr13:48481153-48481270	ENSG00000234689
9	lnc-SUCLA2-3	chr13:48444416-48444464	NONHSAT033689
10	lnc-NUDT15-4	chr13:48477761-48477842	NONHSAT033691
11	lnc-SUCLA2-2	chr13:48504290-48506757	ENSG00000260388.1
12	lnc-SUCLA2-3	chr13:48506205-48506756	NONHSAT033689
13	lnc-SUCLA2-4	chr13:48464985-48466403	XLOC_010601
14	lnc-SUCLA2-3	chr13:48508393-48509188	NONHSAT033689
15	lnc-SUCLA2-1	chr13:48510591-48510908	XLOC_010602
16	lnc-NUDT15-4	chr13:48478857-48479040	NONHSAT033691

No data

(count:1 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	SUCLA2	hsa-miR-122-5p	chr13:48517004-48517027

Variant related genes	Relation type
SUCLA2	TF binding region
LINC00562	TF binding region
LINC00444	TF binding region
SUCLA2	CpG island
LINC00562	CpG island
LINC00444	CpG island
ENSG00000136143	chromatin interactions
ENSG00000260388	chromatin interactions
ENSG00000234689	chromatin interactions
OSBPL9	miRNA target sites

Extended variants
information (count: 4486 )
Associated
traits (count: 123 )

Variant overlapped rSNPs/rCNVs (count:4486 , 50 per page) page: 1 2 3 4 5 6 7 ... 90

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs111519980	chr13:48431009-48431010	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs538708519	chr13:48431060-48431061	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs553709876	chr13:48431081-48431082	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs115736949	chr13:48431097-48431098	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs542595784	chr13:48431111-48431112	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs554862255	chr13:48431137-48431138	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs527863593	chr13:48431190-48431191	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs182646526	chr13:48431250-48431251	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs377651344	chr13:48431262-48431263	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs562988033	chr13:48431285-48431286	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs201093852	chr13:48431321-48431322	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs533299955	chr13:48431334-48431335	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs57916684	chr13:48431337-48431338	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs538683729	chr13:48431366-48431367	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs73483293	chr13:48431375-48431376	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs527879194	chr13:48431379-48431380	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs531645267	chr13:48431389-48431390	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs544857910	chr13:48431402-48431403	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs549277416	chr13:48431403-48431404	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs567588749	chr13:48431406-48431407	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs142029290	chr13:48431423-48431424	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs548916245	chr13:48431430-48431431	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs571197491	chr13:48431449-48431450	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs9534848	chr13:48431473-48431474	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
25	rs150682869	chr13:48431479-48431480	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs76432404	chr13:48431489-48431490	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs536404385	chr13:48431513-48431514	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs117163411	chr13:48431514-48431515	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs77678915	chr13:48431522-48431523	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs535867707	chr13:48431540-48431541	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs78789399	chr13:48431634-48431635	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs556311549	chr13:48431660-48431661	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs139042715	chr13:48431687-48431688	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs111454782	chr13:48431714-48431715	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs112306963	chr13:48431728-48431729	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs186923737	chr13:48431751-48431752	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs74075642	chr13:48431752-48431753	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs561127204	chr13:48431769-48431770	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs202244833	chr13:48431790-48431791	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs386379096	chr13:48431791-48431792	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs77085025	chr13:48431792-48431793	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs77222600	chr13:48431793-48431794	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs531908584	chr13:48431908-48431909	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs550055855	chr13:48431913-48431914	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs564768212	chr13:48431919-48431920	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs1966197	chr13:48431936-48431937	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
47	rs547178343	chr13:48431959-48431960	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs565740222	chr13:48432022-48432023	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs147171431	chr13:48432023-48432024	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs1966196	chr13:48432051-48432052	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:123)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Burkitt''s lymphoma	18698080	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Squamous cell cancer	20885788	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Thyroid cancer	19087340	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	17899364	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	16774939	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17133270	CNVD
Myoepithelioma	18604193	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Trisomy	24170809	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Alveolar rhabdomyosarcoma	16790082	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	18632612	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Prostate cancer	19242612	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	17245344	CNVD
Colorectal cancer	21586687	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Retinoblastoma	19183342	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Developmental delay	21147756	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Melanoma	18172304	CNVD
Retinoblastoma	21504564	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Chronic lymphocytic leukemia	17805327	CNVD
Mental retardation	17502991	CNVD
Retinoblastoma	17502991	CNVD
Bipolar disorder	18458673	CNVD
Liposarcoma	21253554	CNVD
T-cell lymphomas	19863542	CNVD
Cervical cancer	21062161	CNVD
microdeletion syndrome	19284877	CNVD
Ovarian cancer	22355333	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	17053054	CNVD
Multiple myeloma	19135901	CNVD
Autism	18414403	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Prostate cancer	16461572	CNVD
Merkel cell carcinoma	19020549	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Myelofibrosis	22110671	CNVD
Prostate cancer	21088497	CNVD
Colorectal cancer	21645411	CNVD
Breast cancer	22048815	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Glioblastoma multiforme	21750150	CNVD
Chronic lymphocytic leukemia	21049055	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Non-small cell lung cancer	21829676	CNVD
Phyllodes tumor	17334353	CNVD
Retinoblastoma	22278416	CNVD
Glioblastoma multiforme	19435819	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Congenital anomalies of the kidney and urinary tract	20467480	CNVD
Breast cancer	21858162	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Acute myeloid leukemia	21251322	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Prostate cancer	22341455	CNVD

Chromatin state (count:1986 , 50 per page) page: 1 2 3 4 5 6 7 ... 40

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:48424400-48431200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
2	chr13:48427400-48432200	Weak transcription	Muscle Satellite Cultured Cells	--
3	chr13:48428000-48432200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
4	chr13:48428000-48432200	Weak transcription	NHDF-Ad	bronchial
5	chr13:48428000-48432400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
6	chr13:48428000-48432600	Weak transcription	HMEC	breast
7	chr13:48428000-48432600	Weak transcription	HSMM	muscle
8	chr13:48429200-48432400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
9	chr13:48430000-48431800	Enhancers	Primary hematopoietic stem cells short term culture	blood
10	chr13:48430000-48431800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
11	chr13:48430200-48432200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
12	chr13:48430600-48431000	Weak transcription	Primary hematopoietic stem cells	blood
13	chr13:48431000-48432200	Enhancers	Primary hematopoietic stem cells	blood
14	chr13:48431200-48431400	Enhancers	ES-I3 Cell Line	embryonic stem cell
15	chr13:48431400-48431600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
16	chr13:48431600-48433400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
17	chr13:48432000-48433800	Enhancers	HepG2	liver
18	chr13:48432200-48433000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
19	chr13:48432200-48433400	Enhancers	Muscle Satellite Cultured Cells	--
20	chr13:48432200-48433800	Enhancers	NHDF-Ad	bronchial
21	chr13:48432400-48433400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
22	chr13:48432400-48433800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
23	chr13:48432600-48432800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
24	chr13:48432600-48433200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
25	chr13:48432600-48433200	Enhancers	HMEC	breast
26	chr13:48432600-48433200	Enhancers	Osteobl	bone
27	chr13:48432600-48433400	Enhancers	HSMM	muscle
28	chr13:48433000-48433400	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
29	chr13:48433400-48433800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
30	chr13:48433400-48434000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
31	chr13:48439400-48441200	Enhancers	Primary hematopoietic stem cells short term culture	blood
32	chr13:48439400-48441800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
33	chr13:48439600-48440600	Enhancers	Primary hematopoietic stem cells	blood
34	chr13:48439800-48440000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
35	chr13:48440000-48440200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
36	chr13:48440200-48440400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
37	chr13:48440400-48440600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
38	chr13:48440600-48441800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
39	chr13:48443800-48444200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
40	chr13:48444000-48444800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
41	chr13:48444200-48448000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
42	chr13:48447200-48448800	ZNF genes & repeats	ES-UCSF4 Cell Line	embryonic stem cell
43	chr13:48448000-48449000	ZNF genes & repeats	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
44	chr13:48448800-48449400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
45	chr13:48449000-48464200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
46	chr13:48450800-48451000	ZNF genes & repeats	ES-I3 Cell Line	embryonic stem cell
47	chr13:48450800-48451800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
48	chr13:48451000-48451800	Enhancers	Primary hematopoietic stem cells short term culture	blood
49	chr13:48451000-48451800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
50	chr13:48451000-48480200	Weak transcription	ES-I3 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links